Carderock Capital Management Inc Danaher Corp Transaction History

Carderock Capital Management Inc

$379 Million
Q2 2024

A detailed history of Carderock Capital Management Inc transactions in Danaher Corp stock. As of the latest transaction made, Carderock Capital Management Inc holds 21,124 shares of DHR stock, worth $5.74 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares

21,124

Previous 20,404 3.53%

Holding current value

$5.74 Million

Previous $5.1 Million 3.57%

% of portfolio

1.39%

Previous 1.44%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$235.51 - $267.98 $169,567 - $192,945	720 Added 3.53%	21,124 $5.28 Million
Q1 2024 Apr 23, 2024	SELL	$224.58 - $256.19 $1.35 Million - $1.54 Million	-6,000 Reduced 22.72%	20,404 $5.1 Million
Q4 2023 Jan 23, 2024	BUY	$185.1 - $233.13 $72,374 - $91,153	391 Added 1.5%	26,404 $6.11 Million
Q3 2023 Oct 23, 2023	BUY	$233.08 - $265.59 $223,290 - $254,435	958 Added 3.82%	26,013 $6.45 Million
Q2 2023 Jul 25, 2023	BUY	$224.99 - $256.14 $413,981 - $471,297	1,840 Added 7.93%	25,055 $6.01 Million
Q1 2023 Apr 19, 2023	SELL	$239.75 - $277.0 $20,139 - $23,268	-84 Reduced 0.36%	23,215 $5.85 Million
Q4 2022 Jan 20, 2023	BUY	$241.42 - $282.29 $88,601 - $103,600	367 Added 1.6%	23,299 $6.18 Million
Q3 2022 Nov 04, 2022	SELL	$247.06 - $1507.4 $1.81 Million - $11.1 Million	-7,346 Reduced 24.26%	22,932 $5.92 Million
Q2 2022 Jul 21, 2022	SELL	$237.11 - $299.66 $280,026 - $353,898	-1,181 Reduced 3.75%	30,278 $7.68 Million
Q1 2022 Apr 28, 2022	SELL	$257.27 - $315.76 $1.26 Million - $1.55 Million	-4,894 Reduced 13.46%	31,459 $9.23 Million
Q4 2021 Jan 31, 2022	BUY	$292.08 - $329.01 $416,506 - $469,168	1,426 Added 4.08%	36,353 $12 Million
Q3 2021 Oct 29, 2021	BUY	$272.21 - $332.43 $43,281 - $52,856	159 Added 0.46%	34,927 $10.6 Million
Q2 2021 Jul 30, 2021	SELL	$225.08 - $271.69 $126,945 - $153,233	-564 Reduced 1.6%	34,768 $9.33 Million
Q1 2021 May 07, 2021	SELL	$212.38 - $245.9 $71,359 - $82,622	-336 Reduced 0.94%	35,332 $7.95 Million
Q4 2020 Feb 05, 2021	BUY	$212.5 - $245.46 $30,175 - $34,855	142 Added 0.4%	35,668 $7.92 Million
Q3 2020 Oct 27, 2020	BUY	$177.16 - $215.33 $17,716 - $21,533	100 Added 0.28%	35,526 $7.65 Million
Q2 2020 Aug 04, 2020	SELL	$128.7 - $176.83 $23,294 - $32,006	-181 Reduced 0.51%	35,426 $6.26 Million
Q1 2020 May 11, 2020	SELL	$121.39 - $169.05 $1.28 Million - $1.78 Million	-10,532 Reduced 22.83%	35,607 $4.93 Million
Q4 2019 Feb 04, 2020	BUY	$133.47 - $153.48 $31,632 - $36,374	237 Added 0.52%	46,139 $7.08 Million
Q3 2019 Oct 24, 2019	SELL	$135.4 - $146.47 $26,673 - $28,854	-197 Reduced 0.43%	45,902 $6.63 Million
Q2 2019 Jul 15, 2019	BUY	$124.88 - $143.73 $506,513 - $582,968	4,056 Added 9.65%	46,099 $6.59 Million
Q1 2019 Apr 23, 2019	SELL	$97.62 - $132.29 $34,752 - $47,095	-356 Reduced 0.84%	42,043 $5.55 Million
Q4 2018 Feb 14, 2019	SELL	$94.85 - $109.54 $153,846 - $177,673	-1,622 Reduced 3.68%	42,399 $4.37 Million
Q3 2018 Nov 13, 2018	BUY	$98.13 - $108.9 $27,770 - $30,818	283 Added 0.65%	44,021 $4.78 Million
Q2 2018 Jul 16, 2018	BUY	$96.1 - $103.24 $5,573 - $5,987	58 Added 0.13%	43,738 $4.32 Million
Q1 2018 Apr 27, 2018	BUY	$92.16 - $103.8 $7,741 - $8,719	84 Added 0.19%	43,680 $4.28 Million
Q4 2017 Jan 25, 2018	SELL	$85.26 - $94.62 $15,517 - $17,220	-182 Reduced 0.42%	43,596 $4.05 Million
Q3 2017 Nov 15, 2017	SELL	$79.29 - $88.45 $1.03 Million - $1.15 Million	-12,982 Reduced 22.87%	43,778 $3.76 Million
Q2 2017 Aug 10, 2017	BUY	N/A	56,760	56,760 $4.79 Million

Others Institutions Holding DHR

# of Institutions

2,388

Shares Held

563M

Call Options Held

3.94M

Put Options Held

4.1M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $198B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carderock Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Carderock Capital Management Inc with notifications on news.

Account

Carderock Capital Management Inc Danaher Corp Transaction History